Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01666002 · ClinicalTrials.gov registry record · NA

Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser

A NA study of Onychomycosis, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT01666002 is a NA study of Onychomycosis that has completed, run by Stanford University. The registered enrollment target is 27 participants, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01666002, a NA study of Onychomycosis, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The investigators would like to test the treatment of onychomycosis using a 0.65 millisecond pulsed 1064 nm laser fitted with a special onychomycosis handpiece. The investigators will compare the success rates of those receiving laser treatments with untreated patients. This study will provide a clinical basis for determining the relative effectiveness of an increasingly utilized treatment method.

Conditions Studied

Interventions

  • DEVICE Laser Treatment (Pulsed Nd:YAG 1064 nm Laser)

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2011-09
Est. Completion 2013-11
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT01666002

The ClinicalTrials.gov registry entry for NCT01666002 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (71% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 1 intervention - of which Laser Treatment (Pulsed Nd:YAG 1064 nm Laser) is the first listed.

NCT01666002 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01666002 about?

NCT01666002 is a clinical study titled "Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser". The investigators would like to test the treatment of onychomycosis using a 0.65 millisecond pulsed 1064 nm laser fitted with a special onychomycosis handpiece. The investigators will compare the success rates of those receiving laser treatments with untreated patients. This study will provide a cli...

What is the current status of trial NCT01666002?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2011-09. Estimated completion is 2013-11.

What conditions does trial NCT01666002 study?

This clinical trial studies the following conditions: Onychomycosis.

What interventions are being tested in trial NCT01666002?

The interventions under investigation include: Laser Treatment (Pulsed Nd:YAG 1064 nm Laser) (DEVICE).

Who is sponsoring clinical trial NCT01666002?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01666002 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Onychomycosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.